Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leiv Eiriksson Nyskaping (LEN) was a prominent Norwegian innovation company and business incubator based in Trondheim, specifically focused on the commercialization of technology and research from the Norwegian University of Science and Technology (NTNU) and SINTEF. The company served as a critical hub for the life sciences and healthcare sectors in Mid-Norway, providing startups with business development services, seed capital, and specialized infrastructure. LEN managed several investment funds and facilitated public-private partnerships to foster the growth of high-tech ventures. In 2021, the organization merged with T:lab to consolidate the regional innovation ecosystem and expand its support for the Norwegian startup community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leiv Eiriksson Nyskaping.